Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-31

Clinical Trial Update: Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan [Phase 1]

View source ↗

Summary

This Phase 1 study reports the pharmacokinetics of insulin detemir in healthy volunteers from Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin detemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED